OPTIMAL DURATION OF NEOADJUVANT CHEMOTHERAPY - 3 OR 4 VERSUS 6 CYCLESIN 3 SCHEMES FOR OPERABLE BREAST-CANCER

Authors
CHARRIER S FERRIERE JP KWIATKOWSKI F CURE H VANPRAAGH I FEILLEL V ASSIER I BAY JO DAUPLAT J CHOLLET P
Citation
S. Charrier et al., OPTIMAL DURATION OF NEOADJUVANT CHEMOTHERAPY - 3 OR 4 VERSUS 6 CYCLESIN 3 SCHEMES FOR OPERABLE BREAST-CANCER, European journal of cancer, 33, 1997, pp. 360-360
Citations number
NO
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
8
Pages
360 - 360
Database
ISI
SICI code
0959-8049(1997)33:<360:ODONC->2.0.ZU;2-8